Literature DB >> 19324909

VWF and FVIII: the origins of a great friendship.

Sandra L Haberichter1.   

Abstract

Entities:  

Year:  2009        PMID： 19324909      PMCID： PMC2662635          DOI： 10.1182/blood-2009-01-199844

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  9 in total

1.  Expression of factor VIII by murine liver sinusoidal endothelial cells.

Authors:  H Do; J F Healey; E K Waller; P Lollar
Journal:  J Biol Chem       Date:  1999-07-09       Impact factor: 5.157

2.  Factor VIII ectopically targeted to platelets is therapeutic in hemophilia A with high-titer inhibitory antibodies.

Authors:  Qizhen Shi; David A Wilcox; Scot A Fahs; Hartmut Weiler; Clive W Wells; Brian C Cooley; Drashti Desai; Patricia A Morateck; Jack Gorski; Robert R Montgomery
Journal:  J Clin Invest       Date:  2006-07       Impact factor: 14.808

3.  FVIII production by human lung microvascular endothelial cells.

Authors:  Marc Jacquemin; Arne Neyrinck; Maria Iris Hermanns; Renaud Lavend'homme; Filip Rega; Jean-Marie Saint-Remy; Kathelijne Peerlinck; Dirk Van Raemdonck; Charles James Kirkpatrick
Journal:  Blood       Date:  2006-03-28       Impact factor: 22.113

4.  Intracellular interaction of von Willebrand factor and factor VIII depends on cellular context: lessons from platelet-expressed factor VIII.

Authors:  Helen Yarovoi; Alan T Nurden; Robert R Montgomery; Paquita Nurden; Mortimer Poncz
Journal:  Blood       Date:  2005-02-24       Impact factor: 22.113

5.  Genetic induction of a releasable pool of factor VIII in human endothelial cells.

Authors:  J B Rosenberg; J S Greengard; R R Montgomery
Journal:  Arterioscler Thromb Vasc Biol       Date:  2000-12       Impact factor: 8.311

6.  Induction of megakaryocytes to synthesize and store a releasable pool of human factor VIII.

Authors:  D A Wilcox; Q Shi; P Nurden; S L Haberichter; J B Rosenberg; B D Johnson; A T Nurden; G C White; R R Montgomery
Journal:  J Thromb Haemost       Date:  2003-12       Impact factor: 5.824

7.  Factor VIII ectopically expressed in platelets: efficacy in hemophilia A treatment.

Authors:  Helen V Yarovoi; Dubravka Kufrin; Don E Eslin; Michael A Thornton; Sandra L Haberichter; Qizhen Shi; Hua Zhu; Rodney Camire; Steve S Fakharzadeh; M Anna Kowalska; David A Wilcox; Bruce S Sachais; Robert R Montgomery; Mortimer Poncz
Journal:  Blood       Date:  2003-07-24       Impact factor: 22.113

8.  Intracellular cotrafficking of factor VIII and von Willebrand factor type 2N variants to storage organelles.

Authors:  Maartje van den Biggelaar; Alexander B Meijer; Jan Voorberg; Koen Mertens
Journal:  Blood       Date:  2008-12-16       Impact factor: 22.113

9.  Biological effect of desmopressin in eight patients with type 2N ('Normandy') von Willebrand disease. Collaborative Group.

Authors:  C Mazurier; C Gaucher; S Jorieux; M Goudemand
Journal:  Br J Haematol       Date:  1994-12       Impact factor: 6.998
  9 in total
  3 in total

1.  Storage of factor VIII variants with impaired von Willebrand factor binding in Weibel-Palade bodies in endothelial cells.

Authors:  Maartje van den Biggelaar; Eveline A M Bouwens; Jan Voorberg; Koen Mertens
Journal:  PLoS One       Date:  2011-08-31       Impact factor: 3.240

2.  The multiscale backbone of the human phenotype network based on biological pathways.

Authors:  Christian Darabos; Marquitta J White; Britney E Graham; Derek N Leung; Scott M Williams; Jason H Moore
Journal:  BioData Min       Date:  2014-01-25       Impact factor: 2.522

3.  Acquired hemophilia A: a frequently overlooked autoimmune hemorrhagic disorder.

Authors:  Yoshihiko Sakurai; Tomohiro Takeda
Journal:  J Immunol Res       Date:  2014-03-24       Impact factor: 4.818
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.